SPONSORED BIOGRAPHIES INTELLECTUAL PROPERTY
DOMINICK A. CONDE FITZPATRICK, CELLA, HARPER & SCINTO 1290 Avenue of the Americas New York, NY 10104 Tel: 212 218 2204 Fax: 212 218 2200 Email: [email protected] Web: www.fitzpatrickcella.com Dominick A. Conde is Chairman of the firm’s Pharmaceuticals Industry Group and is active in all aspects of the firm’s patent practice, focusing particularly on large-scale litigation matters related to chemistry, pharmaceuticals and pharmaceutical devices and diagnostics. Specific technologies that Mr. Conde has worked with include chemotherapy agents, anti-viral agents, expectorants, anti-bacterial agents, anti-histamines, anti-hypertension agents, filtration devices, writing instruments and fire fighting apparatus. Clients he has represented include BristolMyers Squibb, Reckitt-Benckiser, Daiichi Sankyo, Eli Lilly & Co., Merck & Co., Warner Chilcott, Sanofi-Aventis, Sepracor, Sunovion and Reliable Sprinkler Company. Mr. Conde formerly served as the firm’s Managing Partner and is currently on the firm’s Management Committee. Mr. Conde was recognized as an IP Star in the 2013 edition of Managing Intellectual Property and selected by Managing Intellectual Property Magazine in June 2012 as one of the Top 10 Life Sciences Litigators in the US. He was identified by Legal 500 in 2008, 2009, 2011, and 2012 as a Leading Lawyer in Patent litigation that was called “the best trial lawyer in the country for complex medical cases.” Mr. Conde was recognized in Chambers USA 2011 for his outstanding work in the patent category because “his expertise in pharma work is phenomenal,” in 2012 as being “levelheaded and very service-oriented” and in 2013 he “completely stands out in terms of raw intelligence, lawyering skills and putting together the perfect case.” He is also recognized in IAM Patent 1000 as a leading lawyer that “has a great grasp of the technology and thinks and acts commercially too.” Recent Decisions: Merck & Co., Inc. and Merck Sharp & Dohme Corp. v. Sandoz Inc. D.N.J. 2012. Obtained Summary Judgment On Defendant Sandoz’s Obviousness Defense For Merck’s Antifungal Formulation Patent Covering Cancidas®. Warner Chilcott Laboratories Ireland Limited, et al., v. Mylan Pharmaceuticals Inc. and Mylan Inc. D.N.J. 2011. Obtained Preliminary Injunction Preventing Launch of Mylan’s Generic DORYX® 150 mg Tablet. Representative Matters: • Warner Chilcott against Teva Pharmaceuticals and Watson Laboratories on patents covering Atelvia® used ?? H ?X]Y[????[????\?8?(?Y\???Y?Z[???[??? ][? ???\?[??^?T?]p?? \?Y ? ?X]^YH[??X?[??8?(??\??\??[?? Y?Z[?? \[?[??] ??X??]?Y\?? ][? ???\?[????\? ?[? ?0??H????H?[?? ?X?\ ]?K?8?(??\??\??[?? Y?Z[???] ??X??]?Y\??H ][???\?[???\? ?[? ?0??[??[?? ?X?\ ]?K?8?(?Y\???Y?Z[??]?H\?XX?]]X?[ ?[??[??[??? ][? ???\?[???[??Y\??? \?Y ? ?X]?[??[[??X?[??8?(??[??KP]?[?\?Y?Z[???[??[??][ ??H ][? ?[][?? ?[?][???H ?X]Y[?? [??? ?Y?HRRH????[??\?[?Y ?[??Y???X?[?[??\??8?(?ZZX?H?[??[?Y?Z[???[?\?X? ?Y?XZ?\?^[[?\?XX?]]X?[ ?[?H]? U?^X[?]??Z]???\??[??ZZX?H?[??[??&\??[?X?\????[Z[ H?Y???? ?\??\?HYYX?[?\?8?(??\ ?X??\?XX?]]X?[ ?Y?Z[???[??[??][ ?? ][? ? ?[][?? ??\?[?^0??[?[\??HYYX?][??8?(?Y[\??\?\?]?HY?Z[??][ \HY?[?[? ?? ][? ? ?[][?? ?Y[\??&HY? H ?X??\??[]X?[?^0?? ?? X? ?8?(????\?XX?]]X?[ ?Y?Z[???\??X??]?Y\?? ][? ???\?[??????&H?X\?[?[?KX??\?\?? ?Y????P?H?PT??U?U?P???SKT?T? ???S?? L?L]?[?YH? H[Y\?X?\??]?[???H L L
[? ?L? ?N ??L?^? ?L? ?N ?? [XZ[??X\??? ???H?X?? ????] ?] ?X???[K???H??X?H?X\?\??Y[?H \??\?] H?\?H ?[??H NNH[????\?\?\? ?X?X?H???\^ ][?]Y?][??H\?^ [??]?H??\? ???H^ \?Y[??H[?\? ?\??Y\?XY ?X[??[??[[? ][?[???[??[Y[?]Y?][??[??? ?[?? \?XX?]]X?[ ?[?YX?[?X?[]?X?\?\??X\??&\? ?X?X?H\?[??? ?YX[?H]?\??H X?????Y\?[?? Y[??Y? ? ?[???X?\??Y\???X?HX]\?X[ ?]]?[?]?H \? ? \?X???Z[?\?X[?Y?X? \?[?? \?XX?]]X?[ ?[?[X? ???[ZX?[]?X?\?\??X\?\? ?\??Y\? ?X[??[??[[? ][?]Y?][????Z[????\?? S^Y\???]ZX??[ ?[???[??\?Q?Y\??? \??H[??X?[?[?[??XX?[?\?P?\?XK\? ?V?[?X?K?]X?[ X??\?[\?\ ?\??Z]X??]?Y\??X\?H[?\?XX?XK?[?Y][? ?]Y?][?\??X\?\? ?YH^ \?Y[??H[? ][?\??] ?][? ][?]?[ X][??[??[?[? ???[??Y[ ?\?]?\??H\?YX?[?X?[ [\[??]?X?\? ?Y ?[??Y??\??]HX]\?X[ ?\??X\?\? ?\??Y\?X[?Y?[??\??\?[??? H?]?[??[??\?[??? ????X?\?H ?\?[? H ?\??\?? H?\?x?&\?X[?Y?[Y[???[Z] YK?H\? ?X?[? H?Y[?[X?YH?[??? H]Y?][???[??[?[Y\?X?K?\??X\? ?\?\?Y[?Y?[
L ? [? ? H??][?]Y?][???[??\?Y?K?H ?\?[ ??\?Y[?Y?[YYXH??\?ZYH ? H??8?&\?XY[??][?]? ?X?][?\?? ?
? ? ? K??X?[?X?\?[??\? ?V?[?X?H\?\? ][ ? ??[??[?\?\?[??][ ?K????\??\ X[ ??? H?Y\?[?\??Z] ??Z[?Y?Y\?[?\??Z]Y??\?X[??H???Y[?\? ?V?[?X?H[??\??]Y[??? ][?\? ]K?\? ?V?[?X?H\?XX?]]X?[ ?][ ? ??[??[?\?XX?]]X?[ ?[??][ ? ????? ? L??Y?[?Y ?Y??\??]Y[???[? ][?\? ]H??Z[???Y[?\? ?V?[?X?K??\ ?\?[?]]?HX] \??8?(?\? ?V?[?X?HY?Z[??][ \HY?[?[? ??H ][? ?[][?? ?H ?\?Z[?Y ?[X\?H[?\ ?X??X? ?Y??\??]Y[????8?(?[?Y?[?HX??]?Y\?[?\ ?\?T?Z]X??]?Y\??H ][? ???X?[0??[???[????\? ?Y?8?(?P?Y?Z[??^[[? ???Y K?[??[???[ ? ][? ? ?[][?? ??\ ?p??HXY[??\[\ ?HYYX?[?K?8?(?\?XX?XK? ??X\?K[?[??[??Y?Z[?? H[?]?\??] H????\?\?? ][? ? ?[][?? ? H????\?\? ?? X??[X??^0???8?(?\? ?V?[?X?HY?Z[??]?H? ][? ? ?[][?? ??\??]Y[0??[?[?\ ?X??X?YYX?[?K?8?(???\?? S^Y\???]ZX??Y?Z[???[??[?YH? ][? ? ?[][?? ? H?[??\? ?Y?^?0???8?(?\ ?\??Z]X??]?Y\?Y?Z[????\?[???Y?? ?\??][H ?? X? ?8?(?[ X??\?[\?Y?Z[??[??[\?[?[X? ???][ ]X?[???[X? ???][ ]X??[ X?????K? ??\??[?[\????X][???Y[X?\??\ ??]?[??[?[X? X[ ??\? H]?\????X][?
??\??\?X???N?[Y\?X?[??\?\????X][???]?[??[?\? ?X???? [X?XH?\?\????X][????]??\??^H[?[X? X[ ??\? H]?\????X][???U? ?X[]?Y\??\????X][??[?[X? X[ ??\? H[??] ]H??[?YN?Y[X?\?]?\??] H]?[??] ]N?Y[X?\?H ?X[]?[??] ]B??Q?Q?H??QS??T? ? L???B??